CONVIVO System to Discriminate Healthy Tissues vs Tumor Tissues During Brain Tumor Resection

Stanford University

Overview

The purpose of the study is to do a direct comparison of the CONVIVO system (camera imaging device) with our normal Stanford pathology process. CONVIVO system is being tested to see if the device creates the images very quickly by touching a special camera to the surgical wound.

Primary Objective: The primary objective of this study is to determine the feasibility of using the CONVIVO imaging system to identify tumor type. Secondary Objective: The secondary objectives are to determine the average time needed for tissue visualization with the CONVIVO system as compared to standard cryosectioning, and to describe the ability of the CONVIVO imaging -To describe the ability of the CONVIVO imaging system to generate readable images.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Conditions

Brain Tumor

Interventions

CONVIVO Confocal Endomicroscopy SystemDEVICE

Confocal Laser Endomicroscopy (CEM) system intended for viewing intra-operative blood flow in the cerebral vascular area. Manufacturer - Zeiss

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The subject demonstrates the ability to understand and the willingness to sign a written informed consent document. * The subject is suspected to be suffering from following brain tumor: low-grade glioma, high grade-glioma, metastases, or meningioma. * The subject has been deemed eligible for surgical resection by a practicing Stanford physician. * Macroscopic tumor visualization using IV infusion of 500mg sodium fluorescein is planned as part of the subject's standard of care treatment. * The subject is older than 18 years. * The subject is receiving their surgery at Stanford Hospital. Exclusion Criteria: \* Patients with any kind of contraindication to the use of fluorescein

Outcomes

Primary Outcomes

Feasibility of using the CONVIVO imaging system to identify tumor tissue identified by the operating surgeon

Feasibility is defined as a match between the pathologist determination of a mock diagnosis of type of tumor using CONVIVO images of the planned resection area and the pathologist's cryosection-derived diagnosis used in the course of surgery. This outcome will be expressed as a number without dispersion.

Time frame: 12 months

Secondary Outcomes

Average time needed for tissue visualization with the CONVIVO system as compared to standard cryosectioning

Time for tissue visualization with CONVIVO system: defined as the total number of minutes from start of imaging device use to mock diagnosis. This is calculated by summing the number of minutes from the start of imaging device use to the end of imaging device use in the operating room and the number of minutes from the neuropathologist's start of image review to arrival at a mock diagnosis. Time for standard cryosectioning: defined as the total number of minutes required for standard cryosectioning. This is calculated by summing the number of minutes from when the operating surgeon contacts the neuropathology department to request a frozen section analysis of tissue and ends when the neuropathology department calls the operating room with a suspected diagnosis, as measured by study personnel present in the operating room during the surgery

Time frame: 12 months

Ability of the CONVIVO system capture a readable image

A readable image is defined as an image from which a neuropathologist can make a mock diagnosis. This will be reported as a number without dispersion.

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.